Towards reasonable workload in diagnosis of sentinel lymph nodes: Comparison of two frozen section methods

Histopathology

Volumn 44, Issue 1, 2004, Pages 29-34

  Krogerus, L A ^a   Leidenius, M H K ^a   Toivonen, T S ^a   Von Smitten, K J A ^a  

^a Maria Hospital   (Finland)

Author keywords

Breast cancer; Frozen section; Immunohistochemistry; Imprint cytology; Sentinel node

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; TISSUE SLICE; TUMOR VOLUME;

ADENOCARCINOMA; BREAST NEOPLASMS; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; PATHOLOGY, CLINICAL; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL; WORKLOAD;

EID: 0842286958     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01746.x     Document Type: Article

References (24)

1. Kane JM, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann. Surg. Oncol. 2001: 8; 361-367.
2. Turner RR, Ollila DW, Stern SM et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am. J. Surg. Pathol 1999: 23; 263-267.
3. Schwartz GJ, Giuliano AE, Veronesi U. Consensus, Conference & Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19-22, 2001. Philadelphia, PA. USA. Breast 2002: 11; 362-373.
4. Veronesi U, Paganelli G, Galimberti V et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997: 349; 1861-1867.
5. Viale G, Bosari S, Mazzarol G et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999: 85; 2433-2438.
6. vanDiest PJ, Torrenga H, Meijer S, Meijer CJLM. Pathologic analysis of sentinel lymph nodes. Semin. Surg. Oncol. 2001: 20; 238-245.
7. Cserni G. Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 2001: 27; 532-538.
8. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann. Surg. Oncol 2001: 8; 675-681.
9. Liang WC, Sickle-Santanello B, Nims TA. Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am. J. Surg. 2001: 182; 365-368.
10. Rahusen FD, Torrenga R, vanDiest PJ et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch. Surg. 2001: 136; 1059-1063.
11. Turner RR, Chu KU, Qi K et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel node. Cancer 2000: 89; 574-581.
12. Weiser MR, Montgomery LL, Tan LK et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann. Surg. Oncol. 2002: 8; 145-149.
13. Wong SL, Chao C, Edwards MJ, Simpson D, McMaster KM. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am. J. Surg. 2001: 182; 330-334.
14. Yared MA, Middleton LP, Smith TL et al. Recommendations for sentinel lymph node processing in breast cancer. Am. J. Surg. Pathol. 2002: 26; 377-382.
15. Zurrida S, Mazzarol G, Galimberti V et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann. Surg. Oncol. 2001: 8; 817-820.
16. Gray RJ, Cox CE, Reintgen DS. Importance of missed axillary micrometastases in breast cancer patients. Breast J. 2001: 7; 303-307.
17. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990: 335; 1565-1568.
18. Wilkinson EJ, Hause LL, Hoffman RG. Occult axillary lymph node metastases in invasive breast carcinoma; characteristics of the primary tumour and significance of the metastases. Pathol. Annu. 1982: 17; 67-90.
19. Cote RJ, Peterson HF, Chaiwun B et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999: 354; 896-900.
20. Clayton D, Hopkins CL. Pathologic correlation of prognosis in lymph node positive breast carcinomas. Cancer 1993: 71; 1780-1790.
21. Hartveit F, Lilleng PK, Maehle BO. Efferent vascular invasion in the axillary nodes in breast carcinoma: a potent prognostic factor. Acta Oncol. 2000: 39; 309-312.
22. Klauber-DeMore N, vanZee KJ, Linkov I, Borgen PI, Gerald WL. Biological behavior of human breast cancer micrometastases. Clin. Cancer Res. 2001: 7; 2434-2439.
23. Masuda N, Tamaki Y, Sakita I et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription- polymerase chain reaction in breast cancer patients. Clin. Cancer Res. 2000: 6; 4176-4185.
24. Millis RR, Springall R, Lee AHS, Ryder K, Rytina ERC, Fentiman IS. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br. J. Cancer 2002: 86; 396-401.